Simavita Limited delivered an update to the market on the progress of its PIVOT strategy, to rapidly build a valuable and profitable business. In the past 17 months, the Company has completed a number of major milestones: The material reduction in the monthly cost of operations of the Company. Simavita continues to tightly manage its finances and maintains strong controls over both cash and capital management. Completed a "ground up" rebuild of its primary product offerings. The Company's products now deliver solutions that are inexpensive, easy to use and address real world needs for international and major markets for adult incontinence as well as infant use. Restructured the Company's direct sales and marketing activities to focus on developing highly synergistic partnerships in major markets. Simavita is actively pursuing detailed discussions with a number of major manufacturers in North America and Europe. These discussions are focused upon licensing the Company's industry disruptive, platform technology, AlertPLUSTM for mass market, diaper products. The market opportunity for AlertPLUSTM incorporates: All adult, including aged and disabled users, together with all infant markets; across Europe, Asia Pacific and North American geographies. AssessPLUSTM is Simavita's latest electronic incontinence assessment product. As previously announced, the Company has partnered this product with OneMed in the Nordic countries of Europe and The Netherlands. Interest and sales in these countries is taking significant shape with new sales and new opportunities. Simavita, in partnership with OneMed, is winning business in direct competition with all other competitors in the field. In line with the Company's strategy, Simavita are currently in detailed discussion with a number of parties to distribute AssessPLUSTM for remaining countries within Europe. In the United States, the Company recently completed a clinical trial program with one of organizations. The trial produced excellent clinical and financial results which are currently being presented to senior management. In Australia, the Company has encountered significant headwind with aged care operators who are under increasing cost pressure. Strategy is to focus on government policy and funding initiatives and pursuing this strategy aggressively.